Skip to main content

Post-IPO Equity Life Science Companies

Explore 105 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
105
Total Funding
$386.5M
Avg Funding
$77.3M
Cities
5

Export 105 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Stevenage, United Kingdom
$26.1M
raised

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250.0M
raised

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland
$5.4M
raised

Xlife Sciences focuses on the performance and growth of life science technologies.

Jan 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$75.0M
raised

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$30.0M
raised

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 101 to 105 of 105 companies

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 105 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

105 Life Science Post-IPO Equity Startups (November 2026) — Page 5 | VCBacked